Meanwhile, some key VM-related molecules have been investigated in various aggressive malignant tumors, including hypoxia-inducible factors [11], Ephrin type-A receptor 2 (EphA2) [12, 13] vascular endothelial growth factor (VEGF, also called VEGFA) [14], and matrix metalloproteinases [15]. This evidence concerns the gene VEGFA and cancer.